- Home
- BNTX vs STT Comparison
BNTX vs STT Comparison
Compare BNTX & STT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- STT
- Stock Information
- Founded
- BNTX 2008
- STT 1792
- Country
- BNTX Germany
- STT United States
- Employees
- BNTX N/A
- STT N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- STT Major Banks
- Sector
- BNTX Health Care
- STT Finance
- Exchange
- BNTX Nasdaq
- STT Nasdaq
- Market Cap
- BNTX 26.4B
- STT 32.1B
- IPO Year
- BNTX 2019
- STT N/A
- Fundamental
- Price
- BNTX $105.04
- STT $111.46
- Analyst Decision
- BNTX Strong Buy
- STT Buy
- Analyst Count
- BNTX 14
- STT 13
- Target Price
- BNTX $139.06
- STT $121.38
- AVG Volume (30 Days)
- BNTX 660.2K
- STT 1.7M
- Earning Date
- BNTX 11-03-2025
- STT 10-17-2025
- Dividend Yield
- BNTX N/A
- STT 3.02%
- EPS Growth
- BNTX N/A
- STT 49.61
- EPS
- BNTX N/A
- STT 9.43
- Revenue
- BNTX $3,380,387,551.00
- STT $13,626,000,000.00
- Revenue This Year
- BNTX N/A
- STT $7.22
- Revenue Next Year
- BNTX $13.00
- STT $3.90
- P/E Ratio
- BNTX N/A
- STT $11.81
- Revenue Growth
- BNTX 6.98
- STT 8.59
- 52 Week Low
- BNTX $81.20
- STT $72.81
- 52 Week High
- BNTX $129.27
- STT $118.24
- Technical
- Relative Strength Index (RSI)
- BNTX 55.84
- STT 43.54
- Support Level
- BNTX $101.00
- STT $110.87
- Resistance Level
- BNTX $106.71
- STT $117.00
- Average True Range (ATR)
- BNTX 3.08
- STT 3.24
- MACD
- BNTX 0.43
- STT -0.49
- Stochastic Oscillator
- BNTX 65.13
- STT 50.17
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $49 trillion in assets under custody and administration, and $5.1 trillion in assets under management, as of June 30, 2025, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.